BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:ab123dd957a83685ea8e43664f37488b
DTSTAMP:20260604T173121Z

DTSTART:20221103T090000
DTEND:20221107T180000
SUMMARY:Report on National level training on AEFI and vaccine safety surveillance 
DESCRIPTION:\n\nThe objective of the workshop, held between 3 - 7 November 2022, was to build Nepal's capacity in assessing causality of adverse events following immunization (AEFI) based on WHO’s revised methodology and manage related preparedness and response communications. The technical sessions included:\n\npresentations on basic AEFI concepts,\nglobal AEFI safety surveillance status and progress in in the South-East Asia Region (regarding routine immunization and COVID-19 vaccines),\nAEFI detecting and reporting,\nimmunology of vaccination,\nmethods of AEFI monitoring and investigation, also in in clusters,\nanalysis of vaccine safety data,\noverview of causality assessment,verbal autopsy as part of case investigation,\ndemo of online causality assessment software,\nchallenges in and follow up of causality assessment,\napproach to death/AEFI,\nvaccine safety communication,\nrisk communication and media handling,\nAEFI management including anaphylaxis,\nISRR management,\nvaccine safety monitoring in pregnancy,\nhow AEFI data is processed,\nand Demo vigilise (AEFI data analysis).\n\nAs a follow-up of this training, Nepal’s national AEFI guidelines will be updated in accordance to recent global guidance (Immunization Agenda 2030, GVSB 2.0). Focus will be placed on moving from minimal capacity to maturity level concepts, streamlining the workflow of AEFI surveillance in Nepal, incorporating additional experts in the national AEFI investigation committee meeting and enhancing the engagement of the Department of Drug Administration in vaccine safety surveillance and relevant responses. Using Vigibase to contribute to global vaccine safety surveillance via global data sharing is also being prioritized. \nThe formation of provincial and district level AEFI investigation teams and conduction of provincial level AEFI workshops for capacity building in AEFI reporting, investigation and supporting AEFI committee for causality assessment were emphasized in the workshop.\nThe workshop was facilitated by international and national experts on vaccine safety. Meeting participants represented over 60 participants individuals from throughout the country from Ministry of Health and Population, pediatricians /physicians from federal and provincial hospitals, medical colleges and Surveillance Medical Officers from WHO.\n\nPhoto:&nbsp;AEFI surveillance workshop Nepal November 2022, credit: WHO Nepal

X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">\n<HTML>\n<HEAD>\n<META NAME="Generator" CONTENT="MS Exchange Server version 08.00.0681.000">\n<TITLE></TITLE>\n</HEAD>\n<BODY>\n<!-- Converted from text/rtf format -->\n\n<p><span data-contrast="none"><img src="images/National-level-training-AEFI.jpg" alt="National level training AEFI" width="852" height="350" style="margin-right: 10px; margin-bottom: 10px; margin-left: 10px;" /><br /><br />The objective of the workshop, held between 3 - 7 November 2022, was to build Nepal's capacity in assessing causality of </span><span data-contrast="none">adverse events following immunization</span> <span data-contrast="auto">(</span><span data-contrast="none">AEFI) based on WHO’s revised methodology and manage related preparedness and response communications. The technical sessions included:</span><span data-ccp-props="{"></span></p><br /><ul><br /><li><span data-contrast="none">presentations on basic AEFI concepts,</span></li><br /><li><span data-contrast="none">global AEFI safety surveillance status and progress in in the South-East Asia Region (regarding routine immunization and COVID-19 vaccines),</span></li><br /><li><span data-contrast="none">AEFI detecting and reporting,</span></li><br /><li><span data-contrast="none">immunology of vaccination,</span></li><br /><li><span data-contrast="none">methods of AEFI monitoring and investigation, also in in clusters,</span></li><br /><li><span data-contrast="none">analysis of vaccine safety data,</span></li><br /><li><span data-contrast="none">overview of causality assessment,verbal autopsy as part of case investigation,</span></li><br /><li><span data-contrast="none">demo of online causality assessment software,</span></li><br /><li><span data-contrast="none">challenges in and follow up of causality assessment,</span></li><br /><li><span data-contrast="none">approach to death/AEFI,</span></li><br /><li><span data-contrast="none">vaccine safety communication,</span></li><br /><li><span data-contrast="none">risk communication and media handling,</span></li><br /><li><span data-contrast="none">AEFI management including anaphylaxis,</span></li><br /><li><span data-contrast="none">ISRR management,</span></li><br /><li><span data-contrast="none">vaccine safety monitoring in pregnancy,</span></li><br /><li><span data-contrast="none">how AEFI data is processed,</span></li><br /><li><span data-contrast="none">and Demo vigilise (AEFI data analysis).</span><span data-ccp-props="{"></span></li><br /></ul><br /><p><span data-contrast="none">As a follow-up of this training, Nepal’s national AEFI guidelines will be updated in accordance to recent global guidance (Immunization Agenda 2030, GVSB 2.0). Focus will be placed on moving from minimal capacity to maturity level concepts, streamlining the workflow of AEFI surveillance in Nepal, incorporating additional experts in the national AEFI investigation committee meeting and enhancing the engagement of the Department of Drug Administration in vaccine safety surveillance and relevant responses. Using Vigibase to contribute to global vaccine safety surveillance via global data sharing is also being prioritized. </span><span data-ccp-props="{"></span></p><br /><p><span data-contrast="none">The formation of provincial and district level AEFI investigation teams and conduction of provincial level AEFI workshops for capacity building in AEFI reporting, investigation and supporting AEFI committee for causality assessment were emphasized in the workshop.</span><span data-ccp-props="{"></span></p><br /><p><span data-contrast="none">The workshop was facilitated by international and national experts on vaccine safety. Meeting participants represented over 60 participants individuals from throughout the country from Ministry of Health and Population, pediatricians /physicians from federal and provincial hospitals, medical colleges and Surveillance Medical Officers from WHO.</span><span data-ccp-props="{"><br /><br />Photo:&nbsp;AEFI surveillance workshop Nepal November 2022, credit: WHO Nepal</span></p>\n\n</BODY>\n</HTML>

LOCATION:
END:VEVENT

END:VCALENDAR
